纵横研报
Ticker Detail

600671.SHG

¥19.78+1.18% 天目药业 Drug Manufacturers - General
00Reports China 医疗健康
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
医疗健康 · 综合制药

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces tablets, granules, pills, oral solutions, and other medications; and health food products, including oral liquids, syrups, eye drops, pills, soft capsules, tablets, and granules. It also sells prepared slices of traditional Chinese medicine. In addition, the company operates Chinese medicine clinic; provision of traditional chinese medicine clinic, software development, remote health management, commercial complex management, and internet information services; food business; and sale of health food products. The company was founded in 1958 and is headquartered in Hangzhou, China.

MARKET 市值 2.34B CNY PE 147.8x Fwd 65.8x 52W ¥13.31 – ¥23.44 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -15.1% ROE 8.0% 营业利润率 13.3% 净利润率 8.0%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制